Mach-1 Financial Group’s Boston Scientific BSX Stock Holding History

Mach-1 Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,574	Closed	-$245K	–	178
2025 Q4	$245K	Buy	+2,574	New	+$252K	0.05%	241
2025 Q3	–	Sell	-3,999	Closed	-$430K	–	270
2025 Q2	$430K	Buy	3,999 +293	+8%	+$29.6K	0.13%	133
2025 Q1	$374K	Buy	+3,706	New	+$373K	0.11%	144
2022 Q3	–	Sell	-250	Closed	-$9K	–	387
2022 Q2	$9K	Buy	+250	New	+$10.2K	0.01%	248

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mach-1 Financial Group's BSX Position: Q1 2026 in Review

Mach-1 Financial Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,574 shares — an estimated $245K sold.

Mach-1 Financial Group first reported a position in BSX in Q2 2022 and held it in 4 quarters. The position peaked at $430K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Mach-1 Financial Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Mach-1 Financial Group sold 2,574 Boston Scientific shares in Q1 2026, an estimated $245K.
Mach-1 Financial Group first reported a position in Boston Scientific in Q2 2022 and held it in 4 quarters.
Mach-1 Financial Group's Boston Scientific position peaked at $430K in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.